An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
|2||Not yet recruiting||
Zurich Fistula Cohort Study
Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
† Study has passed its completion date and status has not been verified in more than two years.